HOME ABOUT RRSEARCH GROUPS PUBLICATIONS EDUCATION DOWNLOAD 中文版
  Location: Home > AMHD > News and Events > Announcement
Seminar(June 15, 2017)
2017-09-11 | Author: | From:

SpeakerRhonda D. Kineman, Associate Professor (Dept of Medicine, Section of Endocrinology, Diabetes and Metabolism, University of Illinois at Chicago)

TitleRole of impaired hepatocyte growth hormone signaling in the etiology of non-alcoholic fatty liver disease 

Time: June 15 (Thursday) 2017, 10:00am

Venue: Conference room 237, 2nd floor, Main building, KIZ

Everyone is welcome! 

http://www.kiz.ac.cn/qt/tzgg/xshd/201706/W020170601340709732707.png

Introduction of Rhonda D. Kineman

Rhonda D. Kineman’s research interests include how growth hormone (GH) directly regulates hepatocyte metabolism, injury and repair in adults. Current projects include how GH interacts with insulin to regulate hepatic lipid and carbohydrate metabolism, as well as studies examining the direct effects of GH on pancreatic beta-cell function. They are also interested in how changes in the metabolic environment alter GH production and sensitivity. Up yet, her team has published more than 100 papers on the well known professional journals including Endocrinology, Diabetes, Oncogene and so on. 

Recent Publications

1. Liu Z, Cordoba-Chacon J, Kineman RD, Cronstein BN, Muzumdar R, Gong Z, Werner H, Yakar S. Growth Hormone Control of Hepatic Lipid Metabolism. Diabetes 2016, 65(12):3598

2. Kineman RD, Majumdar N, Subbaiah PV, Cordoba-Chacon J. Hepatic PPAR is not essential for the rapid development of steatosis following loss of hepatic GH signaling, in adult male mice. Endocrinology 2016, 157(5): 1728-1735.

3. Cordoba-Chacon J, Majumdar N, List EO, Diaz-Ruiz A., Frank SJ, Manzano A, Bartrons R, Puchowicz M, Kopchick JJ, Kineman RD. Growth hormone inhibits hepatic de novo lipogenesis in adult mice. Diabetes 2015, 64(9):3093-103.

4. Luque RM, Ibáñez-Costa A, Vieira Neto L, Taboada GF, Hormaechea-Agulla D, Kasuki L, Venegas-Moreno E, Moreno-Carazo A, Ángeles Gálvez M, Soto-Moreno A, Kineman RD, Culler MD, Gahete MD, Gadelha MR, Castaño JP. Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas. Cancer Letters 2015, 359(2):299-306.

Key laboratory of Animal Models and Human Disease Mechanisms

Laboratory of Lipid Metabolism and Diseases

06-02-2017 

Adress:No.32 Jiaochang Donglu Kunming 650223 Yunnan, China Tel:86-871-65197869